Zhe‐Qi Xu
- Biological Psychiatry top 5%
- Neurology top 5%
- Physiology top 5%
- Adenosine and Purinergic Signaling 2
- Immunology top 10%
- Molecular Biology top 10%
- Nicotinic Acetylcholine Receptors Study 4
- Inflammasome and immune disorders 3
- Receptor Mechanisms and Signaling 2
- Extracellular vesicles in disease 1
- Heme Oxygenase-1 and Carbon Monoxide 1
-
- Autophagy in Disease and Therapy 4
-
- Photoreceptor and optogenetics research 1
- Partner nations
- ChinaUnited States
In The Last Decade
Zhe‐Qi Xu
11 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Biological Psychiatry 82
- Neurology 196
- Physiology 83
- Immunology 254
- Molecular Biology 765
Countries citing papers authored by Zhe‐Qi Xu
This map shows the geographic impact of Zhe‐Qi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhe‐Qi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhe‐Qi Xu more than expected).
Fields of papers citing papers by Zhe‐Qi Xu
This network shows the impact of papers produced by Zhe‐Qi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhe‐Qi Xu. The network helps show where Zhe‐Qi Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhe‐Qi Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 24 | |
| 2 | 2021 | 39 | |
| 3 | 2019 | 45 | |
| 4 | 2017 | 59 | |
| 5 | 2017 | 63 | |
| 6 | 2017 | 45 | |
| 7 | 2016 | 12 | |
| 8 | 2016 | 95 | |
| 9 | NLRP3 inflammasome and its inhibitors: a reviewbreakdown → | 2015 | 706 |
| 10 | 2014 | 118 | |
| 11 | The efficacy of Yunnan Baiyao on haemostasis and antiulcer: a systematic review and meta-analysis of randomized controlled trials. | 2014 | 25 |
About Zhe‐Qi Xu
Zhe‐Qi Xu is a scholar working on Physiology, Epidemiology and Nephrology, having authored 11 papers that have together received 1.2k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (4 papers), Nicotinic Acetylcholine Receptors Study (4 papers), Inflammasome and immune disorders (3 papers), Adenosine and Purinergic Signaling (2 papers), Receptor Mechanisms and Signaling (2 papers), Photoreceptor and optogenetics research (1 paper), Extracellular vesicles in disease (1 paper) and Heme Oxygenase-1 and Carbon Monoxide (1 paper). The work is most often cited by research in Biological Psychiatry (82 citations), Neurology (196 citations) and Physiology (83 citations). Zhe‐Qi Xu has collaborated with scholars based in China and United States. Frequent co-authors include Bo‐Zong Shao, Chong Liu, Ding‐Feng Su, Han Bin-Ze, Ping Ke, Xiongwen Chen, Chong Liu, Wei Wei, Wei Wei and Jingjing Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.